Specialty Pharmacy

Eptinezumab-jjmr, the first and only intravenous treatment for migraine prevention, is now commercially available in the United States.

MDS are a group of closely related blood cancers characterized by ineffective production of healthy red blood cells, white blood cells, and platelets, which can lead to anemia and frequent or severe infections.

In a series of studies, researchers described the identification of predictive tools and a new understanding of environmental factors that trigger inflammatory bowel disease.

A new blood test has detected more than 50 types of cancer as well as their location within the body, according to an international team of researchers led by the Dana-Farber Cancer Institute and the Mayo Clinic.

New research in 5 human cancer cell lines revealed interdependencies between a tumor and its host’s microenvironment.

Pharmacists working collaboratively can make an impact, including for patients with more acute diseases.

Genomic profiles measured through circulating free DNA in the blood of patients with breast cancer may provide a more effective way to treat the disease and track its progression.

Researchers examine how stem cells promote neuronal growth in tissue regeneration and in cancer progression.

Further, these natural killer (NK) cells appear to be more effective the earlier they are in development, creating the possibility of an immunotherapy that would not use cells from a patient or a matched donor.

The American College of Rheumatology addresses the prior authorization requirement for some prescription medications, highlighting the significant burden this creates for patients and rheumatology professionals.

The researchers plan to present updated data at the European Society for Medical Oncology Breast Cancer conference in May.

Small cell lung cancer is highly aggressive and fast-growing, typically recurring and progressing rapidly despite the initial response to chemotherapy.

A recent study conducted by Ohio State University suggests that even organized efforts to clean surfaces can fall short, requiring extra cleaning to be done on a daily basis, especially to fight the spread of coronavirus disease 2019 (COVID-19).

New information from the IQVIA “Global Medicine Spending and Usage Trends” report highlights the expected growth of specialty pharmacy spending by 2024.

DCIS is a noninvasive condition in which abnormal cells are found in the lining of a breast duct but have not spread to other tissues in the breast.

For specialty pharmacies, contingency plans for COVID-19 are not as simple as moving a workforce to their remote access solutions.

Ozanimod demonstrated acceptable safety and tolerability in the phase 3 SUNBEAM and RADIANCE part B trials.

New research has examined the details surrounding the signaling molecule interleukin-2, which could lead to more targeted therapies for diseases such as cancer.

Guidelines recommend that Ashkenazi Jewish women discuss genetic testing with physicians, but other women with breast cancer are less likely to receive a recommendation of testing.

A study published in Clinical Cancer Research has shown that using standard-of-care computed tomography (CT) scans in patients with advanced non-small cell lung cancer (NSCLC) can predict tumor sensitivity to 3 systematic cancer therapies by using artificial intelligence (AI).

While remdesivir is not FDA-approved to treat the novel coronavirus, the orphan drug status would provide 7 years of exclusive marketing in the United States and tax credits on research and development costs once the drug was approved.

Research may lead to the development of new types of binding proteins for biological sugar structures, which play a significant role in cancer and infectious diseases.

Patients with a history of cancer have a greater likelihood of developing atrial fibrillation, the most common heart rhythm disorder, compared with the general population.

The new study has found that the lymphedema monitoring technology, marketed by LymphaTech, can effectively detect early arm swelling associated with lymphedema in breast cancer patients.

Trastuzumab-dttb was first approved in January 2019 across all eligible indications, mainly adjuvant treatment of HER2-overexpressing breast cancer, metastatic breast cancer, and metastatic gastric cancer.

The FDA has issued a new guidance to sponsors and health care providers regarding certain Risk Evaluation and Mitigation Strategy-required testing during the coronavirus disease 2019 pandemic.

The phase 3 trial showed a statistically significant improvement in overall survival (OS) and composite complete remission rate.

The growth of the pipeline has led to increases in insurance carriers’ specialty plan spend.

Pharmacy Moms Group special task force develops guidelines as precautions are implemented amid the COVID-19 pandemic.

Only 15% of those at risk are currently using PrEP.